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Abstract
Vascular ultrasound is able to detect endothelial dysfunction, arterial 
structural remodeling and increased arterial stiffness. These alterations have 
been shown to be associated with established and emerging cardiovascular risk 
factors and with incident cardiovascular events. Therefore, vascular ultrasound 
has been proposed to evaluate the role of different risk factors in the initiation 
and progression of atherosclerotic process, to study vascular aging and 
the relationship between arterial stiffness and atherosclerosis, to assess the 
efficacy of life-style and therapeutic interventions, and to improve the estimation 
of individual cardiovascular risk. The present paper provides a critical overview 
of the clinical evidence appraising the association of flow-mediated dilation, 
carotid and femoral intima-media thickness and plaque presence as well as 
local arterial stiffness with cardiovascular risk factors and cardiovascular events.
Keywords: Ultrasound; Biomarkers; Carotid artery; Cardiovascular risk; 
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biological processes, pathogenic processes, or pharmacologic 
responses to a therapeutic intervention” [3]. Therefore, biomarkers 
can be used to detect the burden of subclinical disease in order to 
apply preventive measures, and they should also enable to monitor 
the response of subclinical disease to preventive interventions. Yet, 
robust pathophysiologic, epidemiologic and therapeutic evidence is 
necessary to validate any new biomarker. According to a scientific 
statement from the American Heart Association, biomarker should 
differ between subjects with and without outcome, should predict 
the development of future events over and above established risk 
markers, and its use should improve clinical outcomes when tested in 
a randomized clinical trial [4].
Vascular measures might be particularly informative for the 
assessment of CV risk, as they detect organ damage in different parts 
of vascular bed, are measurable in a non-invasive way, and reflect both 
aging process and adverse impact of established CV risk factors, like 
plasma lipids, smoking, high blood pressure, diabetes, inflammation 
[5].Nowadays, several vascular biomarkers have been proposed. A 
position paper from the European Society of Cardiology Working 
Group on peripheral circulation suggests that the choice of vascular 
biomarker, or their combination, should depend on the clinical 
setting and present comorbidities, and may differ for each individual 
patient [5]. The widespread clinical use of biomarkers depends also on 
their cost-effectiveness, ease of use, clear methodological consensus 
and availability of reference values. From this perspective a vascular 
Ultrasound (US) is an interesting method, as it allows the composite 
evaluation of vascular structure and function in a non-invasive way 
at a relatively low cost (Table 1). Vascular ultrasound can be used to 
assess endothelial function, geometry and stiffness of elastic arteries 
(like carotid artery) and muscular arteries (like brachial and femoral 
artery). 
Endothelial function
The vascular endothelium is a single layer of cells situated at the 
interface between the blood and the vascular wall and releasing a wide 
range of factors that play a central role in the maintenance of vascular 
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Introduction
Cardiovascular (CV) Disease (D) is the leading cause of death 
worldwide. In Europe, CVD is responsible for over 4 millions death 
per year, and causes 42% and 51% of deaths among men and women, 
respectively, compared with 23% and 19% for all cancers [1]. The 
medical cost of CVD has continuously increased in the past years, and 
in 2012 the overall CVD cost in Europe was estimated to be of €196 
billion. In the next 20 years this cost is expected to further escalate.
Yet, CVD is largely preventable, and an early detection of 
individuals at increased risk followed by the implementation of 
life-style and therapeutic interventions can prevent disability and 
death, improve quality of life and reduce the global health-care cost. 
However, the accurate and cost-effective identification of subjects 
at risk is still a challenge. Various risk scores (Framingham Risk 
Score, SCORE Charts, and others) have been developed to guide 
the preventive strategies [2], yet these scores provide estimation of a 
population-based risk rather than quantification of the individual risk. 
Furthermore, a substantial part of population belongs to intermediate 
risk, where it is not clear whether and when an aggressive prevention 
strategy is beneficial and cost effective. 
The use of CV biomarkers in conjunction with risk scores is 
expected to refine the risk stratification of an individual subject 
and to guide the preventive/therapeutic strategy. A “biomarker” 
was defined by the National Institutes of Health as a “characteristic 
that is objectively measured and evaluated as an indicator of normal 
Special Article - Vascular Imaging
Vascular Ultrasound and Cardiovascular Risk Assessment
Kozakova M1 and Palombo C2*
1Department of Clinical and Experimental Medicine, 
University of Pisa, Italy
2Department of Surgical, Medical, Molecular Pathology 
and Critical Care Medicine, University of Pisa, Italy
*Corresponding author: Carlo Palombo, Department 
of Surgical, Medical, Molecular Pathology and Critical 
Care Medicine, University of Pisa, Italy
Received: January 05, 2016; Accepted: February 02, 
2016; Published: February 03, 2016
Austin J Vasc Med 3(1): id1015 (2016)  - Page - 02
Palombo C Austin Publishing Group
Submit your Manuscript | www.austinpublishinggroup.com
health, as they regulate vascular tone, vascular growth, inflammation, 
cell adhesiveness and coagulation [6]. A loss of normal endothelial 
function is believed a key event in the initiation of atherosclerotic 
process [7]. Endothelial function can be measured by different 
techniques, yet the most widely applied technique is brachial artery 
Flow-Mediated Dilation (FMD). FMD is a nitric oxide-mediated 
process using high resolution US to monitor the response of arterial 
diameter to increase in blood flow, which represents a physiologic 
stimulus for endothelial nitric oxide release [8].
FMD has been shown to be adversely associated with CV 
risk factors, like hypertension, diabetes, dyslipidemia, smoking, 
inflammation and abdominal obesity [9-13]. The prognostic value 
of FMD for future CV events has been also tested. In the elderly 
population of the Cardiovascular Health Study (CHS) [14] as 
well as in the population-based cohort of the Multi-ethnic Study 
of Atherosclerosis (MESA) [15], FMD resulted an independent 
predictor for CV events, and in a recent meta-analysis of 23 studies 
including 14 753 subjects, for each 1% increase in FMD the overall 
CVD risk decreased by 13% in diseased population and by 4% in 
asymptomatic population [16]. However, the above-mentioned 
studies also demonstrated that FMD added little to the prognostic 
accuracy of traditional CV risk factors/scores. In the intermediate 
risk population of the MESA, the Net Reclassification Improvement 
(NRI) of FMD for incident coronary heart disease was only 2.4% 
(Table 1), being lower than that of carotid intima-media thickness 
(IMT; 10.2%) [17]. 
FMD has been also used to evaluate the effect of life-style and 
pharmacologic interventions on endothelial function, and numerous 
studies have demonstrated that endothelial dysfunction may improve 
with exercise, weight loss, vitamins, statins or antihypertensive 
treatment [18-21].
Although the concept of FMD is simple, the correct and 
reproducible measurement requires significant expertise, and 
published guidelines suggest a minimum of 100 supervised scans 
before the independent scanning, and at least 100 scans per year to 
maintain competency [22]. Additional methodological issues, like 
the level of inflation pressure, duration of ischemia, localization of 
inflation and the time point at which the effect of hyperemia on artery 
is measured, should be standardized and respected by all centers 
using this method [22-23].
Therefore, at the moment, FMD seems to be above all an interesting 
research tool that can be employed to study the role of emerging CV 
risk factors in the development of atherosclerosis and to monitor the 
effect of interventions and treatment on endothelial function, as the 
method is non-invasive, does not use pharmacologic stimuli, can be 
repeated several times and has an adequate reproducibility in expert 
laboratories [24]. On the other hand, its widespread clinical use for 
the risk stratification is not currently recommended by guidelines 
[25-26].
Carotid/Femoral artery IMT and plaques
Arterial wall is histologically constituted of three layers; 1) the 
inner layer, called tunica intima and composed of a monolayer of 
endothelial cells supported by internal elastic lamina; 2) the middle 
layer, called tunica media and consisting of longitudinal smooth 
muscle cells surrounded by connective tissue with elastic lamellae; 3) 
the outermost layer, called tunica adventitia and formed by connective 
tissue with collagen fibers.IMT is a combined measure of tunica 
intima and tunica media, and may be assessed by high-resolution US 
in different segments of extracranial carotid tree or in large muscular 
arteries as the distance between the intima-luminal and the medial-
adventitial interfaces of the arterial wall. With aging and the presence 
of CV risk factor, IMT increases and loses its double-line aspect 
Description Method of measurement Formulas Clinical Utility
Recommendation/
Level of evidence
for CV prevention
Reference
values
FMD response of BA toreactive hyperemia
B-mode US
RF-based US
direct
measurement
in intermediate risk subjects 
NRI=2.4% for CHD [17] III/B No
Carotid IMT thickness of the near/far wall of CCA/bulb/ICA
B-mode US
RF-based US
direct
measurement
CCA IMT in intermediate risk 
subjects NRI=3.6% for MI or stroke 
[34]
ICA IMT in general 
populationNRI=7% for CHD [36]
IIa/A Yes
Carotid 
Plaques
number
thickness
area
volume
B-mode US direct
measurement
IMT+plaque in general population 
NRI=9.9% for CHD [41]
IMT+plaque in intermediate risk 
subjects NRI=21.7%for CHD [41]
ICA plaque in general population 
NRI=7.3% for CVD [42]
carotid plaque score in general 
population NRI=10.2% for CVD [43]
IIa/A No
Local 
stiffness
changes in vessel diameter/
area to distending pressure
local PWV
B-mode US
RF-based wall 
tracking
distensibility:
∆D/(∆P*D)
compliance:
∆D/∆P
beta index:
ln(Ps/Pd)*D / (∆D)
elastic modulus:
(∆P*D)/ ∆D
Young’s modulus:
(∆P*D)/ (∆D*h)
Bramwell-Hill equation 
[71]
-- -- Yes
Table 1: Vascular biomarkers obtained by ultrasound.
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(Figure 1). Plaque, a focal intima-media thickening, appears first in 
the plaque prone areas [27], i.e. areas with a particular hemodynamic 
pattern, like arterial branching, that is characterized by a low and 
oscillating shear stress and a cyclic reversal flow (Figure 2A). It is 
unclear, whether thickened intima-media complex and the presence 
of plaques represent two different stages or two different phenotypes 
of atherosclerotic process.
Numerous large prospective studies, like Kuopio Ischemic Heart 
Disease study, Atherosclerosis Risk in Communities (ARIC) study, 
CHS, Carotid Atherosclerosis Progression Study, Rotterdam Study, 
have demonstrated the association between carotid IMT and incident 
CVD risk [28-32]. A meta-analysis of 16 studies including 36.984 
participants showed an increase in CV events risk of 16% per 0.1 
mm difference in baseline common carotid artery (CCA) IMT [33]. 
However, the studies evaluating the predictive value of carotid IMT 
over and above established risk scores have been largely negative 
[17,31], and in a meta-analysis of 14 population-based studies (45.828 
participants), the NRI of CCA IMT over Framingham risk score 
was small, being 0.8% for overall cohort and 3.6% for intermediate 
risk subjects [34] (Table 1). Still, the meta-analysis was affected by 
the variability in the IMT methodologies and reporting (number of 
projections, number of segments, mean or maximal IMT value), and 
the evaluation was limited only to CCA IMT, while IMT in carotid 
bifurcation or Internal Carotid Artery (ICA) was not included. It 
seems that IMT in different carotid segments could be associated with 
different CV risk factors and events. In the British Regional Heart 
Study, CCA IMT was strongly associated with risk factors for stroke 
(above all blood pressure) and with prevalent stroke, whereas bulb 
IMT and/or plaques were more associated with ischemic heart disease 
risk factors(smoking, plasma fibrinogen) and prevalent ischemic heart 
disease [35]. In the MESA, only the mean of maximum IMT in ICA, 
but not in CCA, has significant NRI (7.0%) for coronary heart disease 
events [36] (Table 1). The differences between carotid segments can 
be explained by the fact that the atherosclerotic process tends to 
develop initially in the areas of arterial branching (Figure 2A), and 
that increase in CCA IMT may represent not only the atherosclerotic 
process, but also arterial remodeling reflecting smooth muscle cells 
hypertrophy and hyperplasia responding to increase in wall tensile 
stress and pulsatile load [37-38], above all in hypertensive patients.
Carotid plaque (Figure 2 A-D), when compared to IMT, has 
been shown to have a higher diagnostic accuracy for the prediction 
of future coronary artery disease events [39], and the presence of 
carotid plaques predicted CV mortality independently of SCORE 
stratification [40]. In the ARIC population followed for 15.2 years, 
adding plaque and carotid IMT (an average of values obtained in 3 
segments of both the left and right sides) to traditional risk factors 
improved coronary heart disease prediction (NRI= 9.9% in the 
entire population and 21.7% in the intermediate risk groups) [41]. 
Improvement of CVD risk estimation over Framingham risk score 
and traditional risk factors was observed for the plaque presence in 
the ICA (NRI=7.3%) and for the total plaque score (NRI=10.2%) in 
the Framingham Offspring Study cohort and in Chinese population 
[43], respectively (Table 1). 
Figure 1: A) Thin intima-media complex in adolescent; B) Increased thickness 
of intima-media complex in elderly healthy subject; C) Diffuse thickening of 
intima-media complex with structural changes leading to the loss of a 3-layer 
aspect; D) Irregular and markedly thickened CCA wall - development of the 
plaque at the posterior wall.
Figure 2: A) Small fibrotic plaque at carotid bifurcation (atherosclerotic 
prone area); B) Flat, lipid-rich plaque at the posterior wall of CCA; C) Fibrotic 
concentric plaque at carotid bulb; D) Irregular fibrotic plaque at carotid bulb 
and calcified plaque with an irregular surface at the origin of internal carotid 
artery (acoustic shadowing).
Figure 3: Far-wall CCA IMT is automatically measured within the ROI (green 
rectangle), and the values of IMT (QIMT) and diameter (D) are displayed 
beat-to-beat on the screen, together with averaged value (AVG) and standard 
deviation (SD).
A) Far-wall CCA IMT of healthy middle-aged subject (641µm); B)Far-wall 
CCA IMT of patient with dyslipidemia and coronary heart disease (1076 µm).
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Altogether the published data indicate that extensive US 
examination of extracranial carotid tree is required to fully assess 
the degree of atherosclerotic burden. Indeed, the American Society 
of Echocardiography consensus statement specifies that carotid-
artery ultrasonography for CVD risk prediction should be based 
on a thorough scan to detect the presence of plaques, followed by 
measurement of IMT in the CCA [44], and Mannheim consensus 
recommends to image each carotid segment from multiple angels as 
atherosclerotic process is distributed asymmetrically within the vessel 
wall [45].  
In healthy subjects, an average IMT ranges between 400-750 
µm (according to age; Figure 1 A and B), IMT progression rate is 
small - between 1-32µm per year, and the differences between the 25th 
and 75th percentile are < 1 mm [46-49]. Consequently, a high degree 
of precision is required for IMT measurement. A higher accuracy 
and better reproducibility of measurements can be achieved by 
applications of automated edge-tracking algorithms [50], or by the 
use of Radiofrequency (RF)-based echo tracking technology allowing 
automatic measurement of IMT directly from unprocessed RF signal 
(Figure 3) [51]. 
The definition of abnormal IMT values is also important, as 
carotid IMT increases with age and differs between men and women 
[47-48]. It is generally recommended to consider an abnormal carotid 
IMT when greater than the 75th percentile for age and sex [5,44]. 
Several age- and sex-specific reference intervals for CCA IMT as 
measured by B-mode US [52,53] or by RF-based echo tracking system 
were published [47].
The definition and quantification of carotid plaque varied in 
different studies. Mannheim consensus defined plaque as a focal 
thickening that encroaches into the lumen by 0.5 mm or by 50% of 
the surrounding IMT, or when IMT is >1.5 mm [45]. Plaque burden 
has been quantified through plaque number, plaque thickness, 
plaque area [54] or plaque volume as assessed by 3-D US [55]. Some 
investigators suggested a characterization of plaque composition, 
by means of densitometric gray-scale analysis (Figure 4) [56,57], in 
order to distinguish the less echogenic lipid-rich carotid plaques, 
which are associated with a higher risk of ischemic stroke, from stable 
more echogenic fibrotic plaques [58].
The IMT in muscular Femoral Artery (FA) seems to provide 
information similar as or complementary to carotid IMT. FA IMT 
has been shown to be associated with CV risk factors [59,60],extent 
of coronary atherosclerosis [61] and peripheral artery disease [62], 
and patients with peripheral artery disease and hypo-echogenic 
femoral plaques had a 7.24-fold increased CV risk compared with 
patients with hyper-echogenic plaques after adjustment for possible 
confounders [63].
Altogether, a detailed US examination of extracranial carotid 
tree and/or femoral artery, which includes measurement of IMT 
at different segments, quantification of carotid plaque burden and 
evaluation of plaque composition, seems to provide clinically useful 
information on CV risk, above all in intermediate risk subjects (Table 
1).
Local arterial stiffness
Arterial stiffness results from a degenerative process affecting 
mainly the extracellular matrix of elastic arteries under the effect 
of aging and risk factors. Changes in the mechanical properties of 
the vessel wall related to arterial stiffening may activate number of 
mechanisms involved also in the process of atherosclerosis [64]. In 
fact, arterial stiffening and atherosclerosis could be viewed as two 
synergic processes that may potentiate each other in the development 
of vascular changes underlying CVD [65]. Several noninvasive 
methods are now available to estimate large artery stiffness in the 
clinical setting, including segmental Carotid-Femoral (CF) Pulse 
Wave Velocity(PWV) and local arterial stiffness, namely carotid and 
femoral.
Carotid-femoral PWV, an estimate of aortic stiffness, represents 
a gold standard method for arterial stiffness assessment [66,67] and 
is measured directly, as a ratio of distance between two measurement 
points divided by the time required for the pressure propagation 
to travel this distance. Number of studies has demonstrated the 
association between cfPWV and CVD events [68,69], and in a large 
meta-analysis including 16 studies and 17 635 participants [70], the 
age-, sex- and risk factors adjusted hazard ratios per 1SD change 
in logcf-PWV were 1.23, 1.28 and 1.30 for coronary heart disease, 
Figure 4: (A) Video-densitometric (gray-scale) analysis of carotid plaques; 
(B) Histograms of gray levels (256 levels) of echolucent lipid-rich plaque and 
echogenic fibrotic plaque.
Figure 5: Distension values (DIST), diameter (D) and distension curves of 
CCA in: A) Healthy young subject (distension=533 µm); B) Middle-Aged 
subjects (distension=411 µm); C) Diabetic patient (distension=183 µm).
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stroke and CVD, respectively. In addition, cf-PWV improved risk 
prediction in the intermediate risk group by 13%.Carotid-femoral 
PWV is usually measured by tonometry (Complior, SphygmoCor); 
however, Doppler US can be also used, assuming that the pulse wave 
propagation corresponds to the flow wave propagation of spectral 
Doppler [71,72].
Local arterial stiffness is estimated as systo-diastolic changes 
in arterial diameter/area over systo-diastolic changes in distending 
pressure (local pulse pressure). RF-based US technology, thanks 
to its high frame rate and spatial resolution, is capable to track the 
movement of the arterial wall throughout the cardiac cycle with a 
great accuracy [73]. From the real-time distension curves (Figure 
5), maximum and minimum arterial diameters are measured, and 
different indices of arterial stiffness can be calculated, including 
local PWV (Table 1) [74-76]. Local distending pressure used in these 
calculations is estimated converting the distension curve to pressure 
curve by a linear conversion factor and assuming that the difference 
between mean arterial pressure and diastolic pressure is invariant 
along the arterial tree [77].
An assessment of local arterial stiffness on a larger scale became 
feasible only recently, with the introduction of RF-based echo tracking 
systems, and studies evaluating the association of local stiffness with 
risk factors and CVD events are still limited. Carotid stiffness has 
been shown to be associated with blood pressure, plasma lipids, 
smoking, C-reactive protein, diabetes and physical activity [78-80]. A 
recent analysis in the Hoorn Study population followed for 7.6 years 
has demonstrated that both carotid and femoral distensibility indices 
are independently associated with incident CV events and all-cause 
mortality [81].Indeed, the hazard ratios per 1 SD for CV events and 
all cause mortality, respectively, were 1.22 and 1.51 for lower carotid 
distensibility, and1.39 and 1.27 for lower femoral distensibility; these 
hazard ratios were comparable with those obtained in the same 
population for a higher cfPWV (1.56 and 1.13, respectively). The 
age- and sex-specific percentiles of carotid and femoral stiffness in a 
healthy population were estimated and the z-scores were established, 
which enables the comparison of carotid/femoral stiffness values 
between different patients and helps the interpretation of these 
measures [82,83]. 
Therefore, an assessment of local carotid and femoral stiffness by 
means of US is feasible and seems promising; however, this approach 
has to be further validated in prospective studies in order to determine 
its clinical utility in CV risk prediction. 
The role of vascular biomarkers in pediatric populations
Assessment of CV risk in pediatric populations gets increasing 
interest. Although the CV events are rare in children, epidemiologic 
studies have demonstrated that CV risk factors are already identifiable 
in childhood and are predictive of adulthood CVD, type 2 diabetes 
mellitus and hypertension [84]. Moreover, current evidence suggests 
that childhood and adolescence are particularly vulnerable periods of 
life to the effects of cardiometabolic risk factors and later development 
of atherosclerosis, hypertension and diabetes [85]. To slow down the 
progression of atherosclerosis, and thus to reduce the future burden 
of CVD, preventive strategies should be developed [86]. A systematic 
screening of children and adolescents at high cardiometabolic risk 
(like obese children, children with dyslipidemia and type 1 diabetes, 
off-springs of diabetic parents), including also the assessment of 
preclinical vascular damage, may help to apply targeted early lifestyle 
interventions and follow their effect.
Several studies have shown that CV risk profile in childhood may 
influence vascular biomarkers in adulthood. In the Cardiovascular 
Risk in Young Finns Study, the number of risk factors measured 
in 12- to 18-year-old adolescents were directly related to CCA IMT 
measured in young adults at ages 33 through 39 years (P<0.001 for 
both men and women), and remained significant after adjustment 
for contemporaneous risk variables [87]. Data from the three large 
population-based prospective studies (the Bogalusa Heart Study, 
the Cardiovascular Risk in Young Finns Study and Childhood 
Determinants of Adult Health Study) have demonstrated that 
dyslipidemic lipoprotein levels in adolescence (age 12 to 18 years) 
are associated with increased carotid IMT in adulthood (age 29 to 
39 years), and that adolescent dyslipidemic status is more strongly 
associated with high adult IMT than changes in dyslipidemic status 
during follow-up [88].
A major current trend that may significantly increase the future 
burden of CVD is a considerable increase in the prevalence of 
childhood obesity. Obesity in childhood increases the probability of 
being obese as adult, represents a risk for adulthood CV morbidity 
and mortality [89,90], and is associated with wide spectrum of 
vascular changes. Endothelial dysfunction, the first step towards 
atherosclerosis, has been described in childhood obesity [91-93]. 
However, data regarding the impact of obesity on carotid structure 
and function in children are not conclusive; CCA IMT has been 
reported as increased or unchanged [89,94-97], whereas arterial 
stiffness has been found to be increased, unchanged or even 
decreased [94,98-100].These discrepancies could reflect the fact that 
morphological and functional characteristics of large arteries in 
pediatric population are particularly influenced by age, body size, 
and sexual maturation, as adolescence brings an onset of hormonal 
changes and growth that are likely to affect the vasculature [101]. 
During a natural growth and development arterial diameter and 
distensibility increase [102], and this pattern could be amplified in 
obese youths, where increased arterial distension compensates for 
larger luminal diameter and higher blood pressure [103]. Yet, longer-
lasting adaptation to obesity-induced increase in hemodynamic load 
may induce structural changes within the arterial wall leading to 
its stiffening; the time course of this pathological adaptation is not 
known. In a population of 14-year old children followed for 5 years, 
cfPWV at baseline was significantly lower in obese as compared to 
lean subjects [94]; yet during a follow-up period obese subjects had 
significantly higher increase in cfPWV than lean ones (25% vs 3%; 
P<0.0001 vs<0.05, respectively) [104].
CV prevention and risk estimation in pediatric cohorts is 
challenging, and the interpretation of vascular measures is more 
demanding than in adults, as an adaptive remodeling of vessel wall 
in response to physiological development must be considered. A 
large study including 1051nonobese and nonhypertensive children 
aged 6 to 18 years, has tried to establish the sex-specific reference 
charts for CCA IMT and distensibility, and to explore the impact 
of developmental changes in body size and blood pressure on these 
measures [101].
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Conclusion
Vascular US is capable to detect, during a single examination, the 
structural and functional changes of elastic and muscular arteries, 
which increases the probability to detect early organ damage, helps 
to understand the pathophysiology of vascular impairment, may 
improve the assessment of individual CV risk and facilitate the 
decision-making regarding the life-style or therapeutic interventions. 
Nowadays, vascular US is largely used for studying the impact of 
established and emerging risk factors and therapeutic interventions 
on arterial wall, and thus, on initiation, progression and regression 
of arteriosclerotic and atherosclerotic processes. In the next future, 
vascular US could become an interesting tool for the assessment of 
individual CV risk due to its common availability, non-invasiveness, 
absence of radiation and low cost. There is no evidence that single 
vascular measures/biomarkers are superior; in contrast the use of 
different measures could provide complementary information and 
improve the risk assessment. However, the widespread use of vascular 
biomarkers in CV risk assessment and CV prevention requires a clear 
standardization of US methodologies [44,45] and definition of age- 
and sex-specific reference intervals for different vascular measure in 
large populations [47,52,53,82,83].
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